On May 5, 2023, Gilead Sciences Inc announced that at its annual meeting of shareholders held on May 3, 2023, a shareholder proposal requesting the Company to amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting was not approved and Company board nominee Anthony Welters nomination was approved by shareholders.